Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇮🇩ID · Medicine#523K to 10K
- 🇵🇭PH · Medicine#158500 to 3K
- 🇵🇹PT · Medicine#188500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2K to 8K🎙 Weekly cadence·270 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
4K to 16K🇮🇩63%🇵🇭19%🇵🇹19% - Active Followers
Loyal subscribers who consistently listen
1.2K to 4.8K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
No guests detected in recent episodes.
Recent episodes
6.15.2026 - Myxoid Signals
Jun 15, 2026
Unknown duration
6.1.2026 - T Time
Jun 1, 2026
8m 37s
2.16.2026 - Hormone Therapy Reimagined
Feb 16, 2026
7m 57s
1.20.2026 - The Voice
Jan 20, 2026
8m 30s
12.22.2025 - A Positive Breakthrough
Dec 22, 2025
8m 18s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/15/26 | 6.15.2026 - Myxoid Signals | Check out this episode of the QuadCast where we highlight zero margin brain SRS, the benefit of chemoradiation in pancreatic cancer, the ability to reduce radiation dose in myxoid liposarcoma, and more! | — | ||||||
| 6/1/26 | 6.1.2026 - T Time✨ | testosterone replacementprostate cancer+3 | — | SABRGBM | — | testosteronereplacement therapy+5 | — | 8m 37s | |
| 2/16/26 | 2.16.2026 - Hormone Therapy Reimagined✨ | hormone therapyhealth+3 | — | QuadShot News | — | hormone therapyhealth+3 | — | 7m 57s | |
| 1/20/26 | 1.20.2026 - The Voice✨ | immunotherapyrectal cancer+3 | — | TrueBeam | — | immunotherapyrectal cancer+3 | — | 8m 30s | |
| 12/22/25 | 12.22.2025 - A Positive Breakthrough✨ | breakthroughhealth+4 | — | QuadShot News Podcastwww.quadshotnews.com | — | breakthroughhealth+4 | — | 8m 18s | |
| 11/24/25 | 11.24.2025 - Stiff Luck✨ | statinsaortic functioning+4 | — | nimotuzumabanthracycline chemotherapy+3 | — | statinsaortic functioning+6 | — | 6m 33s | |
| 11/3/25 | 11.3.2025 - Score to Settle✨ | elective nodal treatmentbladder cancer+3 | — | QuadShot News Podcastwww.quadshotnews.com | bladder cancerprostate cancer | bladder cancerprostate cancer+3 | — | 7m 52s | |
| 9/15/25 | 9.15.2025 - Ax the Dissection✨ | breast cancerrenal cell carcinoma+3 | — | QuadShot News Podcast | breast canceroligometastatic renal cell carcinoma+1 | axillary dissectionbreast cancer+3 | — | 9m 23s | |
| 9/8/25 | 9.8.2025 - Quick Mayo✨ | radiation therapycancer treatment+3 | — | HPV+SBRT+1 | — | radiation therapyHPV++3 | — | 7m 54s | |
| 8/25/25 | 8.25.2025 - GGO To Go✨ | mediastinal nodal dissectionsmall GGOs+4 | — | Pluvicto | — | GGOsmediastinal nodal dissection+4 | — | 8m 26s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 8/18/25 | 8.18.2025 - The Coccus Race✨ | radiation dermatitisimmunotherapy+4 | — | mupirocinimmunotherapy+4 | — | radiation dermatitismupirocin+5 | — | 11m 12s | |
| 8/11/25 | 8.11.2025 - The FLAME keeps burning | Check out this week's QuadCast as we highlight long term results from FLAME on DIL SIB in prostate cancer, how the benefits of Pluvicto are growing, the thought provoking question of surgical omission in breast cancer, and much more. | — | ||||||
| 8/4/25 | 8.4.2025 - De-Squamate | Check out this week's QuadCast as we highlight de-escalated therapy for cutaneous SCC based on pembro response, a comparison of fluciclovine vs. PSMA PET scan in biochemically recurrent prostate cancer, an important change to HPV+ oropharyngeal staging, and more. | — | ||||||
| 7/28/25 | 7.28.2025 - Just Swell | Check out this week's QuadCast as we highlight the impact of perilesional edema on local failure risk for brain SRS, the benefits of RT in high risk prostate cancer, and much more. | — | ||||||
| 7/21/25 | 7.21.2025 - Depends | Check out this week's QuadCast that highlights the debate over T&O or T&R, the risk of incontinence after salvage, post-prostatectomy radiation, and much more. | — | ||||||
| 7/14/25 | 7.14.2025 - VIOLET | Check out this week's QuadCast as we highlight a PSMA Theranostic contender, new guidelines (and name) for GBM, current management limitations in NSCLC, and more. | — | ||||||
| 6/30/25 | 6.30.2025 - Late TORS Outcomes | Check out this episode of the QuadCast where we highlight de-intensification for HPV mediated oropharyngeal squamous cell carcinoma, how the addition of radium 223 to enzalutamide improves outcomes, and much more. | — | ||||||
| 6/9/25 | 6.9.2025 - NIVONEWS | Check out this week's QuadCast with many highlights from ASCO, including adding nivo to postop CRT in HNSCC, the benefits of immunotherapy in resected MMRd colon cancer, how SRS beat HA-WBRT, and more. | — | ||||||
| 5/20/25 | 5.19.2025 - PLATO-ACT4 | Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sam Marcrom | — | ||||||
| 5/5/25 | 5.5.2025 - Listen To This | Check out this week's QuadCast as we highlight SRS vs. fSRS for hearing preservation in vestibular schwannomas, preoperative immunotherapy in HNSCC, and much more. | — | ||||||
| 4/28/25 | 4.28.2025 - Making Smarter Choices | Check out this week's QuadCast as we highlight the predictive abilities of AI for ADT duration in prostate cancer, how consolidative chemoRT benefits patients with unresectable gallbladder cancer, the benefits of immunotherapy in clear cell GYN cancer, and more. | — | ||||||
| 4/21/25 | 4.21.2025 - Personal Toxicity Profile | Check out this week's QuadCast as we highlight PROSTOX's ability to predict late GU toxicity, why long course chemoradiation may be better than short course RT in rectal cancer, how to identify aggressive chromosomal alterations in meningiomas, and more. | — | ||||||
| 4/7/25 | 4.7.2025 - A Chance Not To Cut | Check out the this week's QuadCast as we highlight omission of surgery in breast cancer patients, best management of small cell lung cancer, adaptive radiation for cervical cancer, the best approach for prostate brachytherapy boost, and more. | — | ||||||
| 3/31/25 | 3.31.2025 - Calculus problem | Check out this week's QuadCast where we highlight the link between dental hygiene and oral mucositis risk, the optimal timing of post-treatment PSMA PET scans, the impressive impact of immunotherapy in MSI-high colorectal cancer, and more. | — | ||||||
| 3/18/25 | 3.18.2025 - DEPEND | Check out this week's QuadCast as we highlight the role of induction chemoimmunotherapy, the scenarios where partial breast irradiation and cosmetic breast surgeries can be considered, and how the Sedlis criteria treatment paradigm remains standard for intermediate risk cervical cancer patients after surgery. | — | ||||||
Showing 25 of 272
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.